SMI
12.604,29
PKT
-19,91
PKT
-0,16
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
16.10.14 | Roche kaufen | Independent Research GmbH | |
16.10.14 | Holcim overweight | JP Morgan Chase & Co. | |
16.10.14 | Holcim overweight | JP Morgan Chase & Co. | |
16.10.14 | UBS Halten | Independent Research GmbH | |
16.10.14 | Novartis Equal weight | Barclays Capital | |
15.10.14 | Roche overweight | Barclays Capital | |
15.10.14 | Holcim buy | UBS AG | |
15.10.14 | Holcim buy | UBS AG | |
15.10.14 | Swiss Re market-perform | Bernstein Research | |
14.10.14 | UBS Buy | UBS AG | |
14.10.14 | Roche buy | Citigroup Corp. | |
14.10.14 | UBS buy | Société Générale Group S.A. (SG) | |
14.10.14 | Novartis overweight | JP Morgan Chase & Co. | |
14.10.14 | Nestlé overweight | JP Morgan Chase & Co. | |
14.10.14 | Novartis Underweight | Morgan Stanley | |
13.10.14 | ABB (Asea Brown Boveri) Outperform | Credit Suisse Group | |
13.10.14 | UBS overweight | JP Morgan Chase & Co. | |
13.10.14 | Holcim buy | Deutsche Bank AG | |
13.10.14 | Roche overweight | JP Morgan Chase & Co. | |
13.10.14 | Swiss Re buy | Jefferies & Company Inc. | |
13.10.14 | Roche buy | UBS AG | |
10.10.14 | Nestlé buy | Citigroup Corp. | |
09.10.14 | Nestlé Neutral | UBS AG | |
09.10.14 | Givaudan buy | UBS AG | |
09.10.14 | Holcim buy | Deutsche Bank AG | |
08.10.14 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
08.10.14 | Givaudan Outperform | Credit Suisse Group | |
08.10.14 | Novartis Hold | Deutsche Bank AG | |
07.10.14 | Roche buy | UBS AG | |
07.10.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
07.10.14 | Roche buy | Deutsche Bank AG | |
07.10.14 | Zurich Insurance Underperform | Bernstein Research | |
02.10.14 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
02.10.14 | Givaudan overweight | JP Morgan Chase & Co. | |
01.10.14 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
30.09.14 | UBS overweight | Morgan Stanley | |
30.09.14 | UBS overweight | JP Morgan Chase & Co. | |
29.09.14 | Roche overweight | JP Morgan Chase & Co. | |
29.09.14 | Roche kaufen | Independent Research GmbH | |
29.09.14 | UBS Underweight | JP Morgan Chase & Co. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.